Vol 26, No 6 (2021)
Research paper
Published online: 2021-10-04

open access

Page views 5973
Article views/downloads 352
Get Citation

Connect on Social Media

Connect on Social Media

Impact of rotational errors of whole pelvis on the dose of prostate-based image-guided radiotherapy to pelvic lymph nodes and small bowel in high-risk prostate cancer

Hiroki Katayama1, Shigeo Takahashi2, Takuya Kobata1, Akihiro Oishi1, Toru Shibata2
Rep Pract Oncol Radiother 2021;26(6):906-914.

Abstract

Background: The target volume increases when the prostate and pelvic lymph nodes (PLNs) are combined, and the fiducial markers (FMs) are placed at the edge of the irradiation field. Thus, the position of FMs may be changed by the rotational errors (REs) of “whole pelvis”. The aim of this study was to examine the impact of REs of “whole pelvis” on the dose of FMs-based image-guided radiotherapy to the PLNs and the small bowel in prostate cancer including the PLNs.

Materials and methods: We retrospectively evaluated 10 patients who underwent prostate cancer radiotherapy involving the PLNs. The position of FMs was calculated from the radiographs obtained before and after the 6D correction of pelvic REs. We simulated the delivery dose considering the daily pelvic REs and calculated the difference from the planned dose in the D98% of the PLN clinical target volume and the D2cc, and V45Gy of the small bowel.

Result: The position of FMs strongly correlated with the pelvic REs in the pitch direction (r = 0.7788). However, the mean delivered doses to PLNs for 10 patients were not significantly different from the planned doses (p = 0.625). Although the D2cc and V45Gy of the small bowel strongly correlated with the pitch rotation of the pelvis, there was no significant difference between the delivered and planned doses (p = 0.922 and p = 0.232, respectively).

Conclusion: The dosimetric effect of pelvic REs on the dose to PLNs and the small bowel was negligible during the treatment course.

 

 

Article available in PDF format

View PDF Download PDF file

References

  1. Gray PJ, Lin CC, Cooperberg MR, et al. Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer. J Natl Cancer Inst. 2015; 107(7): 729–737.
  2. van Nunen A, van der Toorn PPG, Budiharto TCG, et al. Optimal image guided radiation therapy strategy for organs at risk sparing in radiotherapy of the prostate including pelvic lymph nodes. Radiother Oncol. 2018; 127(1): 68–73.
  3. Chung HT, Xia P, Chan LW, et al. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys. 2009; 73(1): 53–60.
  4. Ghadjar P, Fiorino C, Munck Af Rosenschöld P, et al. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol. 2019; 141: 5–13.
  5. Eminowicz G, Dean C, Shoffren O, et al. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy? Br J Radiol. 2014; 87(1037): 20130696.
  6. Adamczyk M, Piotrowski T, Adamiak E, et al. Dosimetric consequences of prostate-based couch shifts on the precision of dose delivery during simultaneous IMRT irradiation of the prostate, seminal vesicles and pelvic lymph nodes. Phys Med. 2014; 30(2): 228–233.
  7. Hsu A, Pawlicki T, Luxton G, et al. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes. Int J Radiat Oncol Biol Phys. 2007; 68(3): 898–902.
  8. Kishan AU, Lamb JM, Jani SS, et al. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015; 91(4): 832–839.
  9. Guckenberger M, Meyer J, Vordermark D, et al. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys. 2006; 65(3): 934–942.
  10. Rossi PJ, Schreibmann E, Jani AB, et al. Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiother Oncol. 2009; 90(3): 353–358.
  11. Lawton CAF, Michalski J, El-Naqa I, et al. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009; 74(2): 383–387.
  12. Ferjani S, Huang G, Shang Q, et al. Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodes. Int J Radiat Oncol Biol Phys. 2013; 87(2): 383–389.
  13. Shang Q, Sheplan Olsen LJ, Stephans K, et al. Prostate rotation detected from implanted markers can affect dose coverage and cannot be simply dismissed. J Appl Clin Med Phys. 2013; 14(3): 4262.
  14. Tanabe S, Utsunomiya S, Abe E, et al. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer. J Appl Clin Med Phys. 2019; 20(6): 53–59.
  15. Liu H, Andrews M, Markovich A, et al. Dosimetric effect of uncorrected rotations in lung SBRT with stereotactic imaging guidance. Phys Med. 2017; 42: 197–202.
  16. Kaiser A, Schultheiss TE, Wong JYC, et al. Pitch, roll, and yaw variations in patient positioning. Int J Radiat Oncol Biol Phys. 2006; 66(3): 949–955.
  17. Zhang Q, Xiong W, Chan MF, et al. Rotation effects on the target-volume margin determination. Phys Med. 2015; 31(1): 80–84.
  18. Kershaw L, van Zadelhoff L, Heemsbergen W, et al. Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins. Int J Radiat Oncol Biol Phys. 2018; 100(1): 68–77.
  19. Cramer AK, Haile AG, Ognjenovic S, et al. Real-time prostate motion assessment: image-guidance and the temporal dependence of intra-fraction motion. BMC Med Phys. 2013; 13(1): 4.
  20. Langen KM, Willoughby TR, Meeks SL, et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2008; 71(4): 1084–1090.
  21. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2000; 48(3): 649–656.



Reports of Practical Oncology and Radiotherapy